H WEHINGER
Overview
Explore the profile of H WEHINGER including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
121
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gomez Dammeier B, WEHINGER H, Fuchs J
Zentralbl Chir
. 2001 Jun;
126(5):399-401.
PMID: 11396251
Neurofibromatosis type 1 (NF 1) is a neuroectodermal tumor in which abdominal manifestations occur in about 25% of cases in addition to the typical cutaneous lesions. A child with a...
2.
von der Wense A, Herrmann B, Deppermann R, Harms F, WEHINGER H
Klin Padiatr
. 1998 Apr;
210(2):51-5.
PMID: 9561956
A 9-year-old body with X-linked agammaglobulinemia developed chronic enteroviral meningoencephalitis (CEMA) caused by echovirus type 6. Intravenous treatment with selected immunoglobulin charges containing high titers against echovirus type 6 or...
3.
Wolfrom C, Frickel C, Fengler R, WEHINGER H, Henze G
Klin Padiatr
. 1994 Jul;
206(4):319-26.
PMID: 7967432
Even in patients with normal renal function, high-dose methotrexate therapy (HDMTX) may be followed by extremely prolonged MTX elimination through alkaline diuresis is performed correctly. By inquiry in Germany, Austria...
4.
Herrmann B, Seewald C, Selb B, WEHINGER H
Monatsschr Kinderheilkd
. 1993 Feb;
141(2):120-3.
PMID: 8384695
Aim Of The Study: The pathogenesis of fifth day fits in newborns has not yet been explained. From 1989-1991 we observed an epidemic occurrence of 21 cases in 1917 hospitalized...
5.
Prindull G, Demuth M, WEHINGER H
Acta Haematol
. 1993 Jan;
90(2):90-3.
PMID: 8285024
The morbidity rates from neoplastic disease have been studied in children below the age of 15 years, residing at the time of their diagnosis within a diameter of 25 km...
6.
Klingebiel T, Berthold F, Treuner J, Schwabe D, Fischer M, FEINE U, et al.
Med Pediatr Oncol
. 1991 Jan;
19(2):84-8.
PMID: 2011100
From 1984 to 1989, 47 children with relapsed, refractory, and/or metastasized neuroblastoma were treated with 131I-metaiodobenzylguanidine (mIBG) in several different treatment combinations. At initial diagnosis, 36 children had Evans stage...
7.
WEHINGER H
Monatsschr Kinderheilkd
. 1988 Dec;
136(12):779-83.
PMID: 3070361
An algorithmic approach to the diagnosis of anemias is presented. It starts with history, physical examination, and a basic laboratory program including erythrocyte morphology. On the basis of the reticulocyte...
8.
WEHINGER H
Klin Padiatr
. 1988 Jul;
200(4):335-8.
PMID: 3172674
For B-All, we treated a five-year-old boy with a combination chemotherapy course including intermediate-dose methotrexate (MTX) with citrovorum factor rescue (CF) two days after a mild sunburn. The insolation inflammation...
9.
Berthold F, FEINE U, Fischer M, Gerein V, Klingebiel T, Maul F, et al.
Klin Padiatr
. 1988 May;
200(3):226-9.
PMID: 3062260
The selective uptake and accumulation of 131J-Metaiodobenzylguanidine in neuroblastoma cells in vivo may be utilized for targeted irradiation. The experience with 32 neuroblastoma patients refractory to conventional high dose chemotherapy...
10.
Treatment of neuroblastoma with 131I-metaiodobenzylguanidine: experience of the Münster/Kassel Group
Fischer M, WEHINGER H, Kraus C, Ritter J, Schroter W
Med Pediatr Oncol
. 1987 Jan;
15(4):196-8.
PMID: 3657707
I-131-metaiodobenzylguanidine was used for treatment of neuroblastoma stage IV in three children after surgery and or chemotherapy had failed to be effective. In two of the children with multilocular lesions,...